[Preclinical trials for predicting fetal risk].
Guittin
P
P
Aventis Pharma, département d'évaluation de la sécurité du médicament, Vitry-sur-Seine, France.
D000014:Abnormalities, Drug-Induced / Q000209:etiology* / Q000517:prevention & control; D000818:Animals; D004353:Drug Evaluation, Preclinical; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D012306:Risk